Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age
Stopped in accordance with the request to close study EP00-402 "EMEA/H/C/000607/MEA 10.2" submitted and adopted by the EMA
Conditions
- Short Children Born Small for Gestational Age (SGA)
Interventions
Sponsor
Sandoz